| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |